Included in National Reimbursement Drug List (NRDL) - Significantly Boosting market Penetration and Driving Valuation Reassessment . HONG KONG, N ...

The global IgA Nephropathy Disease Treatment Market is at the forefront of addressing the growing burden of renal diseases worldwide. With a projected value surpassing USD 485 million by 2028, the ...

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative ...

Wells Fargo initiated coverage of Vera Therapeutics (VERA) with an Overweight rating and $70 price target The firm says atacicept “sets a high ...

Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka Pharmaceutical, Co. Ltd. (Otsuka) announce the decision to submit a Biologics License Application (BLA) in the U.S. for ...

Follow a heart-healthy diet that consists of a good amount of fruits, vegetables, whole grains, and lean proteins. 2. Kidney ...

The U.K.’s Medicines and Healthcare products Regulatory Agency has approved Travere Therapeutics (TVTX)’ medicine sparsentan, or Filspari, to treat primary immunoglobulin A nephropathy. IgA neuropathy ...

Research shows that inflammation of the pancreas, also known as pancreatitis, can increase the risk of developing diabetes, a condition characterized by higher-than-normal blood glucose (sugar) levels ...

IgA nephropathy is the most common primary glomerulonephritis and contributes to kidney failure. Growing evidence exists that the overactivation of the lectin pathway contributes to the pathogenesis ...

The following is a summary of “Association between different proportions of crescents and the progression of IgA nephropathy ...

We achieved important indications expansions for Kisqali in early breast cancer and Fabhalta in IgA nephropathy, and we completed our PSMAfore filing for Pluvicto in the US. With the momentum in ...